Canada Pension Plan Investment Board bought a new position in shares of NewLink Genetics Corporation in the second quarter worth $165,000. NewLink Genetics Corporation has an average rating of "Buy" and an average target price of $25.83. Finally, Zacks Investment Research raised NewLink Genetics Corp from a sell rating to a hold rating in a report on Wednesday, May 10th. NewLink Genetics Corporation (NASDAQ:NLNK)'s short interest is 8.25 million shares, or 41.96% of the float. Finally, Cantor Fitzgerald set a $26.00 target price on NewLink Genetics Corporation and gave the stock a "buy" rating in a research report on Friday, July 28th. Jefferies upgraded the stock to "Buy" rating in Friday, September 8 report.
NewLink Genetics Corporation has a beta of 1.9, offering the possibility of a higher rate of return, but also posing more risk. The rating was maintained by Robert W. Baird on Friday, October 13 with "Buy". Schwab Charles Investment Management holds 0% of its portfolio in NewLink Genetics Corp (NASDAQ:NLNK) for 77,844 shares. As per Friday, September 8, the company rating was upgraded by Robert W. Baird. The firm earned "Neutral" rating on Wednesday, May 11 by SunTrust. The company was maintained on Thursday, August 24 by Jefferies. RTN's SI was 2.73M shares in October as released by FINRA. Its down 5.56% from 138,600 shares previously. With 1.15M avg volume, 2 days are for Raytheon Company (NYSE:RTN)'s short sellers to cover RTN's short positions. The company maintains price to book ratio of 0.00 vs.an industry average at 0.55. The stock decreased 0.54% or $1.02 on October 13, reaching $187.89. Ameritas Investment Prtnrs Inc holds 0.01% in Regency Centers Corp (NYSE:REG) or 3,500 shares. It has outperformed by 10.53% the S&P500.
Investors sentiment decreased to 0.94 in Q2 2017. 93 funds opened positions while 346 raised stakes. The overall volume in the last trading session was 3.58 million shares. Kentucky Retirement System Ins Fund owns 4,006 shares for 0.04% of their portfolio. Pictet Asset Mngmt holds 4.35 million shares or 0.62% of its portfolio. Orbimed Ltd Liability invested in 0.14% or 1.85 million shares. Columbus Circle Investors accumulated 591,765 shares. Fund invested 0.55% in Raytheon Company (NYSE:RTN). 23,757 are held by Bowling Port Limited Company. UBS Asset Management Americas Inc. bought a new stake in NewLink Genetics Corporation in the first quarter valued at $297,000. Gateway Advisers Ltd Liability Company reported 312,572 shares. Art Advsrs Limited Liability Com reported 34,094 shares. Da Davidson, a Montana-based fund reported 40 shares. At one point in the past year, the shares traded as low as $52.15 but has recovered 10.76% since then. It dived, as 35 investors sold HRB shares while 126 reduced holdings. Bridgeway Management holds 30,000 shares.
Supplementing insider data with technical indicators can help an investor form a more complete view on the outlook for a stock. The other 17 are split, though not evenly, between analysts who think you should buy its stock versus those who think you should sell it.
Raytheon Company is a technology company, which specializes in defense and other government markets. It has a 7.43 P/E ratio. An RSI reading over 70 would be considered overbought, and a reading under 30 would indicate oversold conditions. Jefferies maintained Regency Centers Corp (NYSE:REG) on Tuesday, August 23 with "Hold" rating. The firm has "Buy" rating by Jefferies given on Friday, June 23. The rating was upgraded by Argus Research to "Buy" on Monday, December 12. The rating was maintained by Cowen & Co with "Hold" on Monday, September 18. The stock's market cap is $324.54 million. The firm earned "Hold" rating on Thursday, August 3 by Stifel Nicolaus.
A total of 6 firms have reported on the stock. Moreover, Jpmorgan Chase & has 0% invested in NewLink Genetics Corp (NASDAQ:NLNK). NewLink Genetics Corporation had a negative net margin of 161.94% and a negative return on equity of 55.03%. They expect $-0.80 earnings per share, down 48.15% or $0.26 from last year's $-0.54 per share. The company's quarterly EPS surprised Wall Street by as much as -22% to the downside in its last earnings announcement, so investors should note this tendency when assessing consensus estimates. The first sale was made at $10.99 but later the stock became weaker, and closed with a fall of -4.44%. NewLink Genetics Corporation (NLNK) has a market cap of $407.53 million and over the last 12 months, NewLink Genetics Corporation (NASDAQ:NLNK) has gone weaker by -28.09%. It has outperformed by 33.20% the S&P500.
- Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our FREE daily email newsletter.